Showing results (161-170 of 183) with videos related to
Sort By:
Pageof 19
Neuro-Oncology|September 4, 2023
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect groupPhilipp Karschnia, Jorg Dietrich, Francesco Bruno, et al.Neuro-Oncology|June 21, 2024
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directionsJessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, et al.Neuro-Oncology|December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.Journal of Neuro-Oncology|March 24, 2023
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic reviewTamara Ius, Giovanni Sabatino, Pier Paolo Panciani, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|May 12, 2023
Italian Guidelines for the Management of ProlactinomasRenato Cozzi, Renata Simona Auriemma, Ernesto De Menis, et al.Neuro-Oncology|October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect groupNico Teske, Antonio Dono, Jacob S Young, et al.Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.The Lancet. Haematology|May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.Global & Regional Health Technology Assessment|January 17, 2024
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomasMichele Basile, Ilaria Valentini, Roberto Attanasio, et al.Pageof 19